More than 100 pharmacists, medical practitioners and paramedical staff have benefited from a training session on the treatment and use of Sinutab, a new product for sinus.
The training preceded the formal launch and introduction of the product onto the Ghanaian market at a ceremony in Accra at the weekend.
The Sinutab three-way tablet, provides fast and effective symptomatic relief from sinus and nasal congestion, sinus pain and fever.
It is produced and manufactured by Johnson & Johnson, a South Africa-based drug manufacturing company and has Ernest Chemists Limited as its accredited local representatives.
Launching the product, Mr Patrick Asiamah, Brands Manager in-charge of Johnson & Johnson product line at Ernest Chemists Limited, said the two companies understood and appreciated the role and importance of pharmacy support to ensure a successful product launch and therefore found it expedient to engage medical practitioners, pharmacists and paramedical staff in a product training session to precede the launch.
He explained that the training session was aimed at providing the necessary information on the product to make it easier for the practitioners to offer help to all congestion sufferers, who visited their hospitals, clinics and shops.
Mr Asiamah said the drug is effective in treating congestion and a household product in Southern Africa, Europe and the United States of America.
He was optimistic that the introduction of the product in Ghana through the instrumentality of Ernest Chemists Limited will go a long way in addressing the sinus and nasal congestion problems some people suffer in the country.
The Brands Manager of Sinutab, Johnson & Johnson, Riette Erasmus, who took the practitioners through the training session talked on the identification of symptoms that cause congestion, the benefits of the drug to the customer, the dosage and the active ingredients of the drug.